Amyndas Pharmaceuticals Overview
- Year Founded
-
2013
- Status
-
Private
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$12.6K
- Investors
-
4
Amyndas Pharmaceuticals General Information
Description
Developer of a complementary therapeutic designed to provide the transformative therapies for dealing with inflammatory diseases. The company offers drugs for the treatment of inflammatory diseases and age-related macular degeneration, as well as for the treatment of chronic inflammation in dialysis and ischemia-reperfusion, enabling patients to combat inflammatory and kidney diseases.
Contact Information
Website
www.amyndas.comCorporate Office
- PO Box 1045, 125 South King Street
- Suite 2A
- Jackson, WY 83001-1045
- United States
Corporate Office
- PO Box 1045, 125 South King Street
- Suite 2A
- Jackson, WY 83001-1045
- United States
Amyndas Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 15-Nov-2014 | $12.6K | Completed | Generating Revenue | ||
| 3. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 2. Grant | Completed | Generating Revenue | ||||
| 1. University Spin-Out | 01-Jan-2013 | Completed | Startup |
Amyndas Pharmaceuticals Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| The Association of Pharmaceutical Enterprises of Greece | Corporation | |||
| University of Pennsylvania | University | |||
| European Commission | Government | |||
| Penn Center for Innovation | Accelerator/Incubator |
Amyndas Pharmaceuticals FAQs
-
When was Amyndas Pharmaceuticals founded?
Amyndas Pharmaceuticals was founded in 2013.
-
Where is Amyndas Pharmaceuticals headquartered?
Amyndas Pharmaceuticals is headquartered in Jackson, WY.
-
What industry is Amyndas Pharmaceuticals in?
Amyndas Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Amyndas Pharmaceuticals a private or public company?
Amyndas Pharmaceuticals is a Private company.
-
What is Amyndas Pharmaceuticals’s current revenue?
The current revenue for Amyndas Pharmaceuticals is .
-
Who are Amyndas Pharmaceuticals’s investors?
The Association of Pharmaceutical Enterprises of Greece, University of Pennsylvania, European Commission, and Penn Center for Innovation have invested in Amyndas Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process